Do the new weight-loss drugs improve your health?

The FDA has approved three GLP-1 receptor agonist drugs for weight loss. The drugs not only lower blood sugar and weight, but also quiet inflammation, stimulate the production of antioxidants, help repair damaged DNA, and slow the aging of the body’s cells. Evidence suggests that among people who use the drugs for diabetes and obesity, the drugs reduce the risks of kidney disease progression, heart attack, death from heart disease, death from COVID-19, and death from all causes by 15% to 35%.